Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
[Abstract]2025 Jan;87(1):159-169
Lillys Dominance, by the Numbers Eli Lilly (NYSE:LLY | LLY Price Prediction) reported Q1 2026 revenue of $19.80 billion, up 55.5% year over year, with non-GAAP EPS of $8.55 versus a $6.79 consensus
The risk of developing NAION while taking GLP-1 meds is estimated to be 1-2 cases per 10,000 people per year (0.02%)
These requirements vary by plan and are worth confirming with your plan in advance if your prior authorization stalls
Regardless of whether this very optimistic statement is true, what is true is that these drugs are effective for most patients who are obese in causing significant BMI reductions that previously would only be achievable with gastric bypass or sleeve gastrectomy
)
US$ 20.48
US$ 21.92
US$ 25.17
US$ 22.86
US$ 28.87
